在肺动脉压评价中，如没有反流或室间隔缺损如何定量评价？

2021-05-27 MedSci原创 MedSci原创

在肺动脉压评价中，如没有反流或室间隔缺损如何定量评价？

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言

评论区 (5)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1986616, encodeId=81a01986616b7, content=<a href='/topic/show?id=c36433231aa' target=_blank style='color:#2F92EE;'>#动脉压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33231, encryptionId=c36433231aa, topicName=动脉压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=shuangle, createdTime=Mon Dec 06 22:17:37 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1924294, encodeId=10dc192429401, content=<a href='/topic/show?id=a1444624457' target=_blank style='color:#2F92EE;'>#室间隔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46244, encryptionId=a1444624457, topicName=室间隔)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05202500204, createdName=minhuang75_72521584, createdTime=Fri Apr 29 18:17:37 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444703, encodeId=46681444e03d5, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Fri May 28 02:17:37 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460695, encodeId=03c71460695d4, content=<a href='/topic/show?id=42a182045eb' target=_blank style='color:#2F92EE;'>#肺动脉压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82045, encryptionId=42a182045eb, topicName=肺动脉压)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b1e6357266, createdName=hxzhang, createdTime=Fri May 28 02:17:37 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571706, encodeId=1ddf15e170633, content=<a href='/topic/show?id=41e33e76137' target=_blank style='color:#2F92EE;'>#反流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37761, encryptionId=41e33e76137, topicName=反流)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=220d15750403, createdName=feifers, createdTime=Fri May 28 02:17:37 CST 2021, time=2021-05-28, status=1, ipAttribution=)]
2021-12-06 shuangle

#动脉压#

123 0 举报
[GetPortalCommentsPageByObjectIdResponse(id=1986616, encodeId=81a01986616b7, content=<a href='/topic/show?id=c36433231aa' target=_blank style='color:#2F92EE;'>#动脉压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33231, encryptionId=c36433231aa, topicName=动脉压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=shuangle, createdTime=Mon Dec 06 22:17:37 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1924294, encodeId=10dc192429401, content=<a href='/topic/show?id=a1444624457' target=_blank style='color:#2F92EE;'>#室间隔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46244, encryptionId=a1444624457, topicName=室间隔)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05202500204, createdName=minhuang75_72521584, createdTime=Fri Apr 29 18:17:37 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444703, encodeId=46681444e03d5, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Fri May 28 02:17:37 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460695, encodeId=03c71460695d4, content=<a href='/topic/show?id=42a182045eb' target=_blank style='color:#2F92EE;'>#肺动脉压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82045, encryptionId=42a182045eb, topicName=肺动脉压)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b1e6357266, createdName=hxzhang, createdTime=Fri May 28 02:17:37 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571706, encodeId=1ddf15e170633, content=<a href='/topic/show?id=41e33e76137' target=_blank style='color:#2F92EE;'>#反流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37761, encryptionId=41e33e76137, topicName=反流)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=220d15750403, createdName=feifers, createdTime=Fri May 28 02:17:37 CST 2021, time=2021-05-28, status=1, ipAttribution=)]
2022-04-29 minhuang75_72521584

#室间隔#

113 0 举报
[GetPortalCommentsPageByObjectIdResponse(id=1986616, encodeId=81a01986616b7, content=<a href='/topic/show?id=c36433231aa' target=_blank style='color:#2F92EE;'>#动脉压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33231, encryptionId=c36433231aa, topicName=动脉压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=shuangle, createdTime=Mon Dec 06 22:17:37 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1924294, encodeId=10dc192429401, content=<a href='/topic/show?id=a1444624457' target=_blank style='color:#2F92EE;'>#室间隔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46244, encryptionId=a1444624457, topicName=室间隔)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05202500204, createdName=minhuang75_72521584, createdTime=Fri Apr 29 18:17:37 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444703, encodeId=46681444e03d5, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Fri May 28 02:17:37 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460695, encodeId=03c71460695d4, content=<a href='/topic/show?id=42a182045eb' target=_blank style='color:#2F92EE;'>#肺动脉压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82045, encryptionId=42a182045eb, topicName=肺动脉压)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b1e6357266, createdName=hxzhang, createdTime=Fri May 28 02:17:37 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571706, encodeId=1ddf15e170633, content=<a href='/topic/show?id=41e33e76137' target=_blank style='color:#2F92EE;'>#反流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37761, encryptionId=41e33e76137, topicName=反流)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=220d15750403, createdName=feifers, createdTime=Fri May 28 02:17:37 CST 2021, time=2021-05-28, status=1, ipAttribution=)]
2021-05-28 huagfeg

#评价#

73 0 举报
[GetPortalCommentsPageByObjectIdResponse(id=1986616, encodeId=81a01986616b7, content=<a href='/topic/show?id=c36433231aa' target=_blank style='color:#2F92EE;'>#动脉压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33231, encryptionId=c36433231aa, topicName=动脉压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=shuangle, createdTime=Mon Dec 06 22:17:37 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1924294, encodeId=10dc192429401, content=<a href='/topic/show?id=a1444624457' target=_blank style='color:#2F92EE;'>#室间隔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46244, encryptionId=a1444624457, topicName=室间隔)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05202500204, createdName=minhuang75_72521584, createdTime=Fri Apr 29 18:17:37 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444703, encodeId=46681444e03d5, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Fri May 28 02:17:37 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460695, encodeId=03c71460695d4, content=<a href='/topic/show?id=42a182045eb' target=_blank style='color:#2F92EE;'>#肺动脉压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82045, encryptionId=42a182045eb, topicName=肺动脉压)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b1e6357266, createdName=hxzhang, createdTime=Fri May 28 02:17:37 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571706, encodeId=1ddf15e170633, content=<a href='/topic/show?id=41e33e76137' target=_blank style='color:#2F92EE;'>#反流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37761, encryptionId=41e33e76137, topicName=反流)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=220d15750403, createdName=feifers, createdTime=Fri May 28 02:17:37 CST 2021, time=2021-05-28, status=1, ipAttribution=)]
2021-05-28 hxzhang

#肺动脉压#

121 0 举报
[GetPortalCommentsPageByObjectIdResponse(id=1986616, encodeId=81a01986616b7, content=<a href='/topic/show?id=c36433231aa' target=_blank style='color:#2F92EE;'>#动脉压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33231, encryptionId=c36433231aa, topicName=动脉压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=shuangle, createdTime=Mon Dec 06 22:17:37 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1924294, encodeId=10dc192429401, content=<a href='/topic/show?id=a1444624457' target=_blank style='color:#2F92EE;'>#室间隔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46244, encryptionId=a1444624457, topicName=室间隔)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05202500204, createdName=minhuang75_72521584, createdTime=Fri Apr 29 18:17:37 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444703, encodeId=46681444e03d5, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Fri May 28 02:17:37 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460695, encodeId=03c71460695d4, content=<a href='/topic/show?id=42a182045eb' target=_blank style='color:#2F92EE;'>#肺动脉压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82045, encryptionId=42a182045eb, topicName=肺动脉压)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b1e6357266, createdName=hxzhang, createdTime=Fri May 28 02:17:37 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571706, encodeId=1ddf15e170633, content=<a href='/topic/show?id=41e33e76137' target=_blank style='color:#2F92EE;'>#反流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37761, encryptionId=41e33e76137, topicName=反流)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=220d15750403, createdName=feifers, createdTime=Fri May 28 02:17:37 CST 2021, time=2021-05-28, status=1, ipAttribution=)]
2021-05-28 feifers

#反流#

143 0 举报

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

心血管

在肺动脉压评价中，如没有反流或室间隔缺损如何定量评价？

科室

工具

服务